Key result
Platelet-activating factor (PAF) induced dose-dependent vasoconstriction and hyperpermeability in coronary arterioles via an endothelium-dependent and neutrophil-mediated mechanism.
Why the study?
Does Platelet-activating factor (PAF) induce vasoconstriction and hyperpermeability in coronary arterioles?
Does Platelet-activating factor (PAF) induce vasoconstriction and hyperpermeability in coronary arterioles?
PAF mediates coronary microvascular dysfunction through endothelium-dependent vasoconstriction, hyperpermeability, and neutrophil adhesion, highlighting its potential role in ischemic heart disease and reperfusion injury.
No takes yet. Share an insight, caveat, or question.
PAF may mediate coronary microvascular dysfunction; hypothesis-generating for its role in ischemic heart disease and reperfusion injury.
Huang et al. (1998) studied Ischemic heart disease, reperfusion injury, and inflammatory reactions. Platelet-activating factor (PAF) vs. Control conditions was evaluated on Coronary arteriolar function (diameter and permeability) and neutrophil dynamics. Platelet-activating factor (PAF) induced dose-dependent vasoconstriction and hyperpermeability in coronary arterioles via an endothelium-dependent and neutrophil-mediated mechanism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: